How many times have you started to have a conversation with someone about Hepatitis C only to have it blow up in your face? Have you ever heard someone say something about Hep C that didn't seem quite right to you? You were probably right something was amiss. A discussion about Hepatitis C can...
As per Wikipedia, the definition of a stigma is as follows: "Stigma is a word that originally means a "sign", "point", or "branding mark"." Wikipedia goes on to call stigma "A badge of shame, a physical mark of infamy or disgrace." Damn that w...
Recently, the CDC (Center for Disease Control) issued a statement that all Baby Boomers should be tested for Hepatitis C. The question often comes up as to why this particular segment of people is so vulnerable. What does being born between 1945 and 1965 have to do with Hepatitis C? What was di...
Buyer Beware! There are several snake oil salesmen out there who are claiming to have cured their own Hepatitis C with herbs, supplements and parking lot gravel. Okay, maybe not the parking lot gravel but it might as well be. What you need to remember is that there are two different types of...
Most every adult woman (and an occasional man) has enjoyed a manicure and a pedicure at a nail salon or spa. That 30 minute pedicure can be so relaxing but are you aware of the danger lurking in that nail salon? Although few individuals recognize the medical risks associated with this common pr...

It’s been yet another interesting week on the continent; what are our neighbours doing in the tech world and how can we pay compliments to them by emulating their work? (These stories are culled from various news outlets).
Traffic offenders in Kenya won’t have their cake and eat it: the judicial system has partnered with Telecom giant Safaricom to introduce a system that forces drivers to pay traffic fines using a mobile payment system dubbed ‘Faini Chap Chap’. Just last Friday I witnessed a driver kneel before three police officers pleading for forgiveness; assuming the officers denied him mercy, it would streamline the police system’s work if they just made him pay the fine using his mobile phone. We are way behind our East African neighbour and could pick a leaf or two from them.
Elsewhere, in Algeria, a plan is in works to open a research sector to the experience and proficiency offered by foreign scientists. Attracting international talent, fostering brain ‘gain’, and creating partnerships with international universities will serve to produce solutions tailored to Algeria’s needs whilst bolstering the local science and tech sector. The efforts in Algeria (that include raising the budget for research to 1.2 percent of their GDP) come at a time when the European Commission has put in place a strategy to increase the European Union’s involvement in Research with developing nations. Rwanda has already taken steps in Algeria’s direction with the induction of the prestigious Carnegie Mellon University; more can be done along those lines to foster research on the local scene, and like our North African neighbors, proactively seek international talent to compliment work being done here.
In Nigeria, it was not enough to create an electronic wallet programme under the auspices of the Ministry of Agriculture and Rural Development; ten million lucky farmers across the country will receive mobile phones (a colossal figure given Rwanda’s population stands at eleven million). Farmers will receive fertilizer and seed support through their phones. Rwanda is not far off: with the e-Soko project, farmers are able to make market pricing decisions, for example. Rwanda’s mobile penetration rate is 45 per cent, in rural areas the percentage has gone from 4.3 per cent in 2005 to 55.6 per cent in 2011. Clearly, we have the devices; we are left with the homework of creating an ‘app economy’ that shapes and changes how business is done here in Rwanda.
The KwaZulu-Natal Research Institute in South Africa is set to inaugurate an $8 million HIV, TB research facility with a goal of driving innovation to control these killer diseases. This highlights a recent movement on the continent to take matters into our own hands: the research institute will create an alliance between South African and American scientists, creating a stage for skills transfer and opportunities for young scientists in South Africa. 3.1 per cent of Rwandans between the ages of 15-49 are infected with HIV/AIDS; given our ambitions to become a knowledge based economy, human capital is key, and its initiatives like those at the KwaZulu-Natal institute that we need on ground to deal with the epidemic as well as equip the Rwandan medical landscape to proactively find cures for different diseases. Preventive methods that drive down the HIV/AIDS percentage are paramount to steering a healthy population towards the common vision that we have set before ourselves. Have a great week folks!
By Alline Akintore
Please sign the ATC Salvage Therapy Petition Join us in asking Congressman Alcee Hastings and Congresswomen Maxine Waters to send a ‘Dear Colleague’ letter to Anthony Fauci, Director of NIAID, asking for the federal facilitation of apricitabine (ATC). ATC is a phase III nucleoside reverse transcriptase inhibitor (NRTI) that has been shown to be safe and effective in treating people with HIV. It works against viruses that are resistant to several other nukes and could ...
Researchers from Johns Hopkins Children’s Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School announced today at CROI2013 the discovery of the first infant functionally cured of HIV. The baby, a female now two and a half years old, received 3 HIV medications when brought to the hospital at 30 hours old. Viral load tests were performed during the first few weeks that showed a rapidly decreasing viral load which reached ...
At the 19th International AIDS Conference (AIDS 2012) in Washington D.C., the CDC reported that only 1 out of 4 HIV patients in the U.S. have HIV under control, which is defined as complete viral suppression. Warning bells should be ringing in the scientific and HIV advocacy communities. While much progress has been made in the last three decades in the treatment of HIV, tens of thousands of people living with HIV (PLWH) are currently struggling to construct viable treat...
Paige Rawl is 17 and HIV positive, but while her life has been shaped by HIV it isn't ruled by it. When Paige Rawl starts her senior year at Indianapolis’s Herron High School next month, she'll be cheer captain and a member of the student government and prom committee. This summer, the 17-year-old held down a part-time job at Hollister, hawking the popular Southern California-inspired clothing brand. The all-American girl — who happens to be HIV positive. Paige was in...
The HIV community has been abuzz with the August FDA approval of what had been termed “the Quad”, the second one-pill-once-a-day combination antiretroviral drug. Marketed by Gilead under the name Stribild, the drug contains two NRTIs (tenofovir and emtricitabine), an integrase inhibitor (elvitegravir) and an integrase booster (cobicistat) and is approved for use in treatment naïve patients with either drug resistant or wild type virus. In comparison to Atripla, the first...

Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for SUSTIVA® (efavirenz), including dosing recommendations for...

California and other states would be pressured to amend or repeal criminal laws that single out HIV-positive people under a bipartisan bill co-authored and introduced this week by Rep. Barbara...
Mission Statement
At HIV Haven we wish to provide our readers with vital cutting edge information to help expand HIV knowledge and promote activism, particularly that which works towards an end to the HIV pandemic. It is our desire to bring to you the scientific, medical and social advances that given the appropriate attention and support, could change the course of the HIV pandemic, lessen the devastating effects of HIV and AIDS, better the quality and quantity of life for people living with HIV and even yield an eventual end to the HIV pandemic. We also provide the basics of HIV transmission and treatment.
We will focus on issues such as innovative drug development, strategic activist campaigns, HIV relationships and novel HIV and HIV cure research. We also will bring you advances in Hepatitis C (HCV), a common HIV co-infection. Whether you are living with HIV/AIDS, HIV and HCV, love someone who is, are an activist, advocate, researcher, physician or just an interested party, we hope here at HIV Haven we can help you find what you are looking for.